Back to Trades
Sell4
Hims & Hers Health, Inc.
HIMS
Total Value
$416.1K
Net $306.5K sold
Sales
$306.5K
1 transaction
Company Information
- Company Name
- Hims & Hers Health, Inc.
- Ticker Symbol
- HIMS
- CIK
- 0001773751
Insider Information
- Name
- Okupe Oluyemi
- Role
- Chief Financial Officer
- Location
- SAN FRANCISCO, CA
Officer
Filing Details
- Filing Date
- Jan 7, 2026
- Transaction Date
- Jan 5, 2026
- Accession Number
- 0001907056-26-000002
- Form Type
- 4
- Net Trading Amount
- -$306.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 5, 2026 | Class A Common Stock | 2,178 | $5.01 | Exercise | $10.9K |
| Jan 5, 2026 | Class A Common Stock | 3,808 | $11.53 | Exercise | $43.9K |
| Jan 5, 2026 | Class A Common Stock | 9,070 | $33.79 | Sale | $306.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 5, 2026 | Derivative | 2,178 | $5.01 | Exercise | $10.9K |
| Jan 5, 2026 | Derivative | 3,808 | $11.53 | Exercise | $43.9K |
Footnotes
- (F1)The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
- (F2)Includes 368 shares acquired on November 20, 2025, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.
- (F3)Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.61-$33.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- (F4)The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.
- (F5)The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.